Mechanisms of innate immune surveillance by pulmonary surfactant proteins and their clinical application to respiratory infection.
肺表面活性蛋白的先天免疫监视机制及其在呼吸道感染中的临床应用。
基本信息
- 批准号:16390235
- 负责人:
- 金额:$ 9.09万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purposes of this project are to investigate the molecular mechanisms of ligand recognition by pulmonary surfactant proteins (SP-A and SP-D ; pulmonary collectins) and Toll-like receptors and of the collectin-mediated bacterial phagocytosis by macrophages, and to establish the molecular basis for the clinical application to respiratory infections.1.We have shown that Mycobacterium avium is a ligand for pulmonary collectins, and that SP-D binds to lipoarabinomannan derived from M.avium. In addition, we have found that SP-A and SP-D enhance the phagocytosis of M.avium by increased activity of mannose receptor on macrophages.2.SP-A but not SP-D has been shown to augment the phagocytosis of Streptococcus pneumoniae and Staphylococcus aureus by alveolar macrophages. SP-A activates casein kinase 2 and increases cell surface localization of scavenger receptor A (SR-A). Thus, it is suggested that SP-A augment SR-A-mediated phagocytosis by casein kinase 2-dependent machanism. Analysis of SP- … More A/SP-D chimeras has revealed that the C-terminal Cys204-Cys218 is important for the SP-A's stimulatory effect on phagocytosis.3.We constructed a soluble form of recombinant extracellular TLR4 domain consisting of the region Glu24-Leu631 (sTLR4) and analysed the interactions with LPS and MD-2. MD-2 binds to the N-termnal region (Glu24-Pro34) of sTLR4. sTLR4 alone by itself does not bind to lipid A, but sTLR4 increases the binding affinity of MD-2 to lipid A and the amount of lipid A bound to MD-2. The sTLR4-MD-2 complex inhibits the binding of LPS to the cells expressing TLR4/MD-2. In addition, intratracheal instillation of sTLR4 and MD-2 dampens pulmonary inflammation caused by LPS in mice.4.SP-A and SP-D have been shown to directly bind to the extracellular domains of TLR2 and TLR4. Their bindings are Ca2+-dependent but are thought to be via protein-protein interaction because both collectins bind to deglycosylated sTLR proteins. Epitope mapping for anti-SP-D monoclonal antibodies and their effects on the SP-D binding to sTLRs have revealed that SP-D binds to sTLR proteins through the carbohydrate recognition domain (CRD). Collagenase-resistant fragment of SP-A (CRF), which has been shown to form trimer consisting of the CRD and the neck, binds to sTLR proteins with significantly lower affinity than that of wild type octadecameric SP-A. In addition, the ability of CRF to inhibit smooth LPS-induced NF-κB activation in TLR4/MD-2-tranfected cells was significantly attenuated. The results demonstrate the importance of supratrimeic oligomer formation by the N-terminal collagenous domain in interaction with TLR and in modulation of innate immune function by pulmonary collectins. Less
本课题的目的是研究肺表面活性物质蛋白(SP-A和SP-D)和Toll样受体识别配体的分子机制,以及巨噬细胞介导的集合素介导的细菌吞噬作用的分子机制,为临床应用于呼吸道感染奠定分子基础。1.我们已经证明,鸟分枝杆菌是肺集合素的配基,并且SP-D与来源于禽分枝杆菌的阿拉伯甘露聚糖结合。此外,我们还发现SP-A和SP-D通过增加巨噬细胞上甘露糖受体的活性来增强对禽类支原体的吞噬作用。2.SP-A而不是SP-D能够增强肺泡巨噬细胞对肺炎链球菌和金黄色葡萄球菌的吞噬作用。SP-A激活酪蛋白激酶2,增加清道夫受体A(SR-A)在细胞表面的定位。因此,提示SP-A通过酪蛋白激酶2依赖的机制增强SR-A介导的吞噬功能。SP-…协议分析更多的A/SP-D嵌合体表明,C端的Cys204-Cys218在SP-A的吞噬刺激作用中起重要作用。3.我们构建了由Glu24-Leu631区域(STLR4)组成的重组胞外TLR4结构域的可溶性形式,并分析了其与内毒素和MD-2的相互作用。MD-2与sTLR4的N-末端区域(Glu24-Pro34)结合。STLR4本身不与脂质A结合,但sTLR4增加了MD-2与脂质A的结合亲和力和与MD-2结合的脂质A的量。STLR4-MD-2复合体抑制内毒素与表达TLR4/MD-2的细胞的结合。此外,气管内滴注sTLR4和MD-2可抑制脂多糖引起的小鼠肺部炎症。4.已证明SP-A和SP-D可直接与TLR2和TLR4的胞外区结合。它们的结合依赖于钙离子,但被认为是通过蛋白质-蛋白质相互作用进行的,因为这两种集合素都与脱糖的sTLR蛋白结合。抗SP-D单抗的表位定位及其对SP-D与sTLR结合的影响表明,SP-D通过糖识别结构域(CRD)与sTLR蛋白结合。胶原酶抗性的SP-A片段(CRF)与sTLR蛋白的结合亲和力显著低于野生型十八聚体SP-A。此外,CRF抑制脂多糖诱导的TLR4/MD-2细胞中的NF-κB活化的能力显著减弱。这些结果证明了N端胶原结构域在与TLR相互作用中形成房上性低聚物,以及在肺集合素调节天然免疫功能中的重要性。较少
项目成果
期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Surfactant protein gene expression for detection of lung carcinoma cells in peripheral blood.
检测外周血中肺癌细胞表面活性蛋白基因表达。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Yonesaka;K.;Tamura;K.;Kurata;T.;Satoh;T.;Ikeda;M.;Fukuoka;M.;Nakagawa;K.;Yamamoto O
- 通讯作者:Yamamoto O
The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain.
CD14 区域跨越氨基酸 57-64,对于与胞外 Toll 样受体 2 结构域的相互作用至关重要。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Zeller GC;Hirahashi J Schwarting A;Sharpe AH;Kelley VR;Sano H;Takeyama K;Mitsuzawa H;Nishitani C;Ono K;Yamada C;Konishi M;Uemura T;Piboonpocanum S;Iwaki D
- 通讯作者:Iwaki D
Alloiococcus otitidis is a ligand for collectins and Toll-like receptor 2, and its phagocytosis is enhanced by collectins
- DOI:10.1002/eji.200535542
- 发表时间:2006-06-01
- 期刊:
- 影响因子:5.4
- 作者:Konishi, Masanori;Nishitani, Chiaki;Kuroki, Yoshio
- 通讯作者:Kuroki, Yoshio
The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
- DOI:10.1016/j.bbrc.2005.01.021
- 发表时间:2005-03
- 期刊:
- 影响因子:3.1
- 作者:C. Nishitani;H. Mitsuzawa;Naoki Hyakushima;H. Sano;N. Matsushima;Y. Kuroki
- 通讯作者:C. Nishitani;H. Mitsuzawa;Naoki Hyakushima;H. Sano;N. Matsushima;Y. Kuroki
Structural analysis of leucine rich repeat (LRR) variants in proteins associated with human diseases.
与人类疾病相关的蛋白质中富含亮氨酸重复序列 (LRR) 变体的结构分析。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Kurata T;Tamura K;Okamoto I;Satoh T;Nakagawa K;Fukuoka M.;Konishi M;Matsushima N
- 通讯作者:Matsushima N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUROKI Yoshio其他文献
KUROKI Yoshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUROKI Yoshio', 18)}}的其他基金
Mechanisms of host defense against pulmonaryinfection, inflammation and injury by surfactant proteins and studies on clinical applications
表面活性蛋白抵抗肺部感染、炎症和损伤的宿主防御机制及临床应用研究
- 批准号:
20390232 - 财政年份:2008
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Host defense system in the lung using pulmonary surfactant proteins and Toll-like reosptors
使用肺表面活性蛋白和 Toll 样重反应器的肺部宿主防御系统
- 批准号:
18390241 - 财政年份:2006
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical application for pathophysiological analysis, diagnosis and treatment of lung diseases by genes and their products expressed in alveolar type II cells.
肺泡II型细胞表达的基因及其产物在肺部疾病病理生理学分析、诊断和治疗中的临床应用。
- 批准号:
12557057 - 财政年份:2000
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of innate immune host defense mediated by lung-surfactant proteins A and D
肺表面活性蛋白A和D介导的先天免疫宿主防御的分子机制
- 批准号:
12470136 - 财政年份:2000
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Host defense mechanism by pulmonary surfactant proteins A and D thiir clinical application
肺表面活性蛋白A和D的宿主防御机制及其临床应用
- 批准号:
10557058 - 财政年份:1998
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Host defense mechanism and modulation of lipid metabolism by pulmonary surfactant proteins
宿主防御机制及肺表面活性蛋白对脂质代谢的调节
- 批准号:
09670159 - 财政年份:1997
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of lung discases by analysis of surfactant protein A and its receptor.
通过表面活性蛋白A及其受体分析肺疾病的分子机制。
- 批准号:
07457147 - 财政年份:1995
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulatory roles of pulmonary surfactant apoprotein and its receptor in metabolism of lung diseases.
肺表面活性物质脱辅基蛋白及其受体在肺部疾病代谢中的调节作用。
- 批准号:
03670406 - 财政年份:1991
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
Collectin-12激活单核细胞及补体旁路途径参与肾小管损伤的机制研究
- 批准号:82000730
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CAREER: Decoding the Code of Glycan-Collectin Interactions: Computational Engineering of Surfactant Proteins for Tailored Glycan Recognition
职业:解码聚糖-收集素相互作用的密码:用于定制聚糖识别的表面活性剂蛋白的计算工程
- 批准号:
2338401 - 财政年份:2024
- 资助金额:
$ 9.09万 - 项目类别:
Continuing Grant
Roles of human surfactant collectin variants in the susceptibility of COVID-19
人类表面活性剂集合素变体在 COVID-19 易感性中的作用
- 批准号:
10510706 - 财政年份:2022
- 资助金额:
$ 9.09万 - 项目类别:
Roles of human surfactant collectin variants in the susceptibility of COVID-19
人类表面活性剂集合素变体在 COVID-19 易感性中的作用
- 批准号:
10662530 - 财政年份:2022
- 资助金额:
$ 9.09万 - 项目类别:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
使用集合素表面活性剂蛋白 A (SP-A) 预防早产
- 批准号:
10403521 - 财政年份:2019
- 资助金额:
$ 9.09万 - 项目类别:
Prevention of Preterm Birth Using the Collectin Surfactant Protein A (SP-A)
使用集合素表面活性剂蛋白 A (SP-A) 预防早产
- 批准号:
9913576 - 财政年份:2019
- 资助金额:
$ 9.09万 - 项目类别:
Characterisation of glycan ligands recognised by collectin-11 in ischaemic kidney and development of a specific antagonistic probe
缺血肾中collectin-11识别的聚糖配体的表征以及特异性拮抗探针的开发
- 批准号:
MR/R010757/1 - 财政年份:2018
- 资助金额:
$ 9.09万 - 项目类别:
Research Grant
Novel mechanism of complement activation by membrane-type collectin CL-P1
膜型集合素 CL-P1 激活补体的新机制
- 批准号:
17K08615 - 财政年份:2017
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the involvement of collectin CL-K1 in the pathogenesis of 3MC syndrome and elucidation of its molecular mechanism
集合素CL-K1参与3MC综合征发病机制的研究及其分子机制的阐明
- 批准号:
16K19045 - 财政年份:2016
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Collectin-11 as a trigger of the innate immune response in renal transplantation
Collectin-11 作为肾移植中先天免疫反应的触发因素
- 批准号:
MR/M012263/1 - 财政年份:2015
- 资助金额:
$ 9.09万 - 项目类别:
Research Grant
Pulmonary collectin regulates the severity of Streptococcus pneumoniae infection
肺集合素调节肺炎链球菌感染的严重程度
- 批准号:
15K09181 - 财政年份:2015
- 资助金额:
$ 9.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




